eMedicine Specialties > Obstetrics and Gynecology > Obstetrical Complications

Macrosomia: Differential Diagnoses & Workup

Author: Allahyar Jazayeri, MD, PhD, Medical Director of Perinatal Services, Bellin Health Hospital Center
Coauthor(s): Mary Jazayeri, WHNP, ; Karen Burr, WHNP,
Contributor Information and Disclosures

Updated: Dec 3, 2007

Differential Diagnoses

Diabetes Mellitus and Pregnancy
Obesity
Postterm Pregnancy

Other Problems to Be Considered

Polyhydramnios
Inaccurate gestational age
Multiple gestations
Pelvic masses
Fibroid uterus
Shoulder dystocia

Workup

Laboratory Studies

  • A glucose tolerance test at 24-28 weeks of gestation screens for gestational diabetes.
  • Early glucose screening is necessary for women with risk factors for the development of diabetes (eg, obesity, strong family history of diabetes, prior pregnancy affected by macrosomia or gestational diabetes).
  • In insulin controlled diabetic mothers, serial testing for presumed macrosomic fetuses is indicated with nonstress testing performed biweekly or with contraction stress testing performed weekly.15 The use of a biophysical profile can be substituted for heart rate monitoring, but, in the presence of diabetes, some authors indicate a need for biweekly testing.
  • Neonatal evaluation for hypoglycemia, polycythemia, hyperbilirubinemia, and electrolyte abnormalities is indicated in all macrosomic newborns because maternal hyperglycemia is the most common cause and sometimes this diagnosis is not made in the mother prior to delivery of her child.
  • Long-term follow-up care of these infants is needed because they are at risk for obesity and perhaps diabetes in later life.

Imaging Studies

  • Ultrasonographic measurements to obtain estimated fetal weights are indicated when clinical assessments indicate a uterine size greater than that expected for the gestational age. An examination within 1-2 weeks of delivery showing an abdominal circumference of 35 cm or larger should alert the clinician to anticipate a fetus with a birth weight of 4000 g or more. The definitive diagnosis can only be made after delivery of the neonate.
  • Ultrasonography of the fetus and its size can be useful for identifying macrosomic infants. In 1999, Jazayeri et al showed that abdominal circumference measurements made within 2 weeks of delivery can be predictive of a birth weight greater than 4000 g.16
    • A measurement of 35 cm or more identified more than 90% of newborns with a birth weight greater than 4000 g and occurred in only 18% of the population.
    • An abdominal circumference measurement within 2 weeks of delivery had sensitivity, specificity, and positive and negative predictive values of approximately 90%.
    • Abdominal circumference measurements in patients at risk for macrosomia can provide some clues to the size of the fetus and thus allow appropriate preparations for delivery (see Surgical Care).
  • Ben-Haroush et al17 reported ultrasonography to be an accurate way of estimating birth weight as a screening measure. In suspected macrosomic fetuses, sensitivity was 75% and specificity was 65% resulting in a positive predictive value of 57% and a negative predictive value of 81%. In controls, sensitivity was 32% and specificity was 92% resulting in a positive predictive value of 33% and a negative predictive value of 90%. In the overall population of 298 newborns, sensitivity was 56% and specificity was 88% resulting in a positive predictive value of 48% and a negative predictive value of 91%.

More on Macrosomia

Overview: Macrosomia
Differential Diagnoses & Workup: Macrosomia
Treatment & Medication: Macrosomia
Follow-up: Macrosomia
References

References

  1. Martin JA, Hamilton BE, Sutton PD, Ventura SJ, Menacker F, Kirmeyer S. Births: final data for 2004. Natl Vital Stat Rep. Sep 29 2006;55(1):1-101. [Medline].

  2. Okun N, Verma A, Mitchell BF, Flowerdew G. Relative importance of maternal constitutional factors and glucose intolerance of pregnancy in the development of newborn macrosomia. J Matern Fetal Med. Sep-Oct 1997;6(5):285-90. [Medline].

  3. Spellacy WN, Miller S, Winegar A, Peterson PQ. Macrosomia--maternal characteristics and infant complications. Obstet Gynecol. Aug 1985;66(2):158-61. [Medline].

  4. McFarland LV, Raskin M, Daling JR, Benedetti TJ. Erb/Duchenne's palsy: a consequence of fetal macrosomia and method of delivery. Obstet Gynecol. Dec 1986;68(6):784-8. [Medline].

  5. Mondestin MA, Ananth CV, Smulian JC, Vintzileos AM. Birth weight and fetal death in the United States: the effect of maternal diabetes during pregnancy. Am J Obstet Gynecol. Oct 2002;187(4):922-6. [Medline].

  6. Mulik V, Usha Kiran TS, Bethal J, Bhal PS. The outcome of macrosomic fetuses in a low risk primigravid population. Int J Gynaecol Obstet. Jan 2003;80(1):15-22. [Medline].

  7. Catalano PM. Management of obesity in pregnancy. Obstet Gynecol. Feb 2007;109(2 Pt 1):419-33. [Medline].

  8. GIBSON JR, McKEOWN T. Observations on all births (23, 970) in Birmingham, 1947. VII. Effect of changing family size on infant mortality. Br J Soc Med. Jul 1952;6(3):183-7. [Medline].

  9. Thomson AM, Billewicz WZ, Hytten FE. The assessment of fetal growth. J Obstet Gynaecol Br Commonw. Sep 1968;75(9):903-16. [Medline].

  10. Di Renzo GC, Rosati A, Sarti RD, Cruciani L, Cutuli AM. Does fetal sex affect pregnancy outcome?. Gend Med. Mar 2007;4(1):19-30. [Medline].

  11. Hackmon R, Bornstein E, Ferber A, Horani J, O'Reilly Green CP, Divon MY. Combined analysis with amniotic fluid index and estimated fetal weight for prediction of severe macrosomia at birth. Am J Obstet Gynecol. Apr 2007;196(4):333.e1-4. [Medline].

  12. Institute of Medicine. Nutritional status and weight gain. In: Nutrition During Pregnancy. National Academies Press; 27-233.

  13. Smith GC, Smith MF, McNay MB, Fleming JE. The relation between fetal abdominal circumference and birthweight: findings in 3512 pregnancies. Br J Obstet Gynaecol. Feb 1997;104(2):186-90. [Medline].

  14. Chauhan SP, Hendrix NW, Magann EF, Morrison JC, Kenney SP, Devoe LD. Limitations of clinical and sonographic estimates of birth weight: experience with 1034 parturients. Obstet Gynecol. Jan 1998;91(1):72-7. [Medline].

  15. ACOG Practice Bulletin. Clinical Management Guidelines for Obstetrician-Gynecologists. Number 60, March 2005. Pregestational diabetes mellitus. Obstet Gynecol. Mar 2005;105(3):675-85. [Medline].

  16. Jazayeri A, Heffron JA, Phillips R, Spellacy WN. Macrosomia prediction using ultrasound fetal abdominal circumference of 35 centimeters or more. Obstet Gynecol. Apr 1999;93(4):523-6. [Medline].

  17. Ben-Haroush A, Yogev Y, Bar J, et al. Accuracy of sonographically estimated fetal weight in 840 women with different pregnancy complications prior to induction of labor. Ultrasound Obstet Gynecol. Feb 2004;23(2):172-6. [Medline].

  18. Rouse DJ, Owen J, Goldenberg RL, Cliver SP. The effectiveness and costs of elective cesarean delivery for fetal macrosomia diagnosed by ultrasound. JAMA. Nov 13 1996;276(18):1480-6. [Medline].

  19. Combs CA, Singh NB, Khoury JC. Elective induction versus spontaneous labor after sonographic diagnosis of fetal macrosomia. Obstet Gynecol. Apr 1993;81(4):492-6. [Medline].

  20. Acker DB, Gregory KD, Sachs BP, Friedman EA. Risk factors for Erb-Duchenne palsy. Obstet Gynecol. Mar 1988;71(3 Pt 1):389-92. [Medline].

  21. Buchanan TA, Kjos SL, Montoro MN, et al. Use of fetal ultrasound to select metabolic therapy for pregnancies complicated by mild gestational diabetes. Diabetes Care. Apr 1994;17(4):275-83. [Medline].

  22. Walkinshaw SA. Dietary regulation for 'gestational diabetes'. Cochrane Database Syst Rev. 2000;(2):CD000070. [Medline].

  23. Parker JD, Abrams B. Prenatal weight gain advice: an examination of the recent prenatal weight gain recommendations of the Institute of Medicine. Obstet Gynecol. May 1992;79(5 ( Pt 1)):664-9. [Medline].

  24. Cogswell ME, Serdula MK, Hungerford DW, Yip R. Gestational weight gain among average-weight and overweight women--what is excessive?. Am J Obstet Gynecol. Feb 1995;172(2 Pt 1):705-12. [Medline].

  25. Bianco AT, Smilen SW, Davis Y, et al. Pregnancy outcome and weight gain recommendations for the morbidly obese woman. Obstet Gynecol. Jan 1998;91(1):97-102. [Medline].

  26. ACOG Committee Opinion number 315, September 2005. Obesity in pregnancy. Obstet Gynecol. Sep 2005;106(3):671-5. [Medline].

  27. Boney CM, Verma A, Tucker R, Vohr BR. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics. Mar 2005;115(3):e290-6. [Medline].

  28. Jovanovic-Peterson L, Peterson CM, Reed GF, Metzger BE, Mills JL, Knopp RH. Maternal postprandial glucose levels and infant birth weight: the Diabetes in Early Pregnancy Study. The National Institute of Child Health and Human Development--Diabetes in Early Pregnancy Study. Am J Obstet Gynecol. Jan 1991;164(1 Pt 1):103-11. [Medline].

  29. Alexander GR, Himes JH, Kaufman RB, et al. A United States national reference for fetal growth. Obstet Gynecol. Feb 1996;87(2):163-8. [Medline].

  30. Babinszki A, Kerenyi T, Torok O, et al. Perinatal outcome in grand and great-grand multiparity: effects of parity on obstetric risk factors. Am J Obstet Gynecol. Sep 1999;181(3):669-74. [Medline].

  31. Benedetti TJ, Gabbe SG. Shoulder dystocia. A complication of fetal macrosomia and prolonged second stage of labor with midpelvic delivery. Obstet Gynecol. Nov 1978;52(5):526-9. [Medline].

  32. Deter RL, Hadlock FP. Use of ultrasound in the detection of macrosomia: a review. J Clin Ultrasound. Oct 1985;13(8):519-24. [Medline].

  33. Dooley SL, Metzger BE, Cho NH. Gestational diabetes mellitus. Influence of race on disease prevalence and perinatal outcome in a U.S. population. Diabetes. Dec 1991;40 Suppl 2:25-9. [Medline].

  34. Ecker JL, Greenberg JA, Norwitz ER, et al. Birth weight as a predictor of brachial plexus injury. Obstet Gynecol. May 1997;89(5 Pt 1):643-7. [Medline].

  35. Flamm BL, Goings JR. Vaginal birth after cesarean section: is suspected fetal macrosomia a contraindication?. Obstet Gynecol. Nov 1989;74(5):694-7. [Medline].

  36. Gonen O, Rosen DJ, Dolfin Z, et al. Induction of labor versus expectant management in macrosomia: a randomized study. Obstet Gynecol. Jun 1997;89(6):913-7. [Medline].

  37. Homko CJ, Sivan E, Nyirjesy P, Reece EA. The interrelationship between ethnicity and gestational diabetes in fetal macrosomia. Diabetes Care. Nov 1995;18(11):1442-5. [Medline].

  38. Juntunen K, Kirkinen P, Kauppila A. The clinical outcome in pregnancies of grand grand multiparous women. Acta Obstet Gynecol Scand. Sep 1997;76(8):755-9. [Medline].

  39. Klebanoff MA, Mills JL, Berendes HW. Mother's birth weight as a predictor of macrosomia. Am J Obstet Gynecol. Oct 1 1985;153(3):253-7. [Medline].

  40. Larsen CE, Serdula MK, Sullivan KM. Macrosomia: influence of maternal overweight among a low-income population. Am J Obstet Gynecol. Feb 1990;162(2):490-4. [Medline].

  41. Little RE, Sing CF. Genetic and environmental influences on human birth weight. Am J Hum Genet. Jun 1987;40(6):512-26. [Medline].

  42. McFarland MB, Trylovich CG, Langer O. Anthropometric differences in macrosomic infants of diabetic and nondiabetic mothers. J Matern Fetal Med. Nov-Dec 1998;7(6):292-5. [Medline].

  43. Raio L, Ghezzi F, Di Naro E, et al. Perinatal outcome of fetuses with a birth weight greater than 4500 g: an analysis of 3356 cases. Eur J Obstet Gynecol Reprod Biol. Aug 15 2003;109(2):160-5. [Medline].

  44. Sermer M, Naylor CD, Gare DJ, et al. Impact of increasing carbohydrate intolerance on maternal-fetal outcomes in 3637 women without gestational diabetes. The Toronto Tri-Hospital Gestational Diabetes Project. Am J Obstet Gynecol. Jul 1995;173(1):146-56. [Medline].

  45. Spellacy WN. Shoulder dystocia risks. Am J Obstet Gynecol. Apr 1999;180(4):1047. [Medline].

  46. Toohey JS, Keegan KA, Morgan MA, et al. The "dangerous multipara": fact or fiction?. Am J Obstet Gynecol. Feb 1995;172(2 Pt 1):683-6. [Medline].

Further Reading

Keywords

megasomia, macrosomic neonate, macrosomic newborn, large for gestational age, LGA, body mass index, BMI, maternal diabetes, maternal obesity, maternal weight gain, hyperglycemia, shoulder dystocia, birth trauma, birth canal laceration, neonatal morbidity, neonatal injury, maternal injury, cesarean delivery, cesarean section, caesarean delivery, caesarean section, cesarean birth, caesarean birth, advanced gestational age, perineal laceration, vaginal laceration, cervical laceration, still birth, stillborn, multiparity, multi-parity, grand multiparity, diabetic pregnancy, poorly controlled diabetes, diabetes, diabetes mellitus, gestational diabetes, macrosomic pregnancy, excessive maternal weight gain, undiagnosed glucose intolerance

Contributor Information and Disclosures

Author

Allahyar Jazayeri, MD, PhD, Medical Director of Perinatal Services, Bellin Health Hospital Center
Allahyar Jazayeri, MD, PhD is a member of the following medical societies: American College of Obstetricians and Gynecologists, American Institute of Ultrasound in Medicine, Association of Professors of Gynecology and Obstetrics, Society for Gynecologic Investigation, and Society for Maternal-Fetal Medicine
Disclosure: Nothing to disclose.

Coauthor(s)

Mary Jazayeri, WHNP, 
Disclosure: Nothing to disclose.

Karen Burr, WHNP, 
Disclosure: Nothing to disclose.

Medical Editor

Gerard S Letterie, DO, Associate Clinical Professor, Medical Director of In-vitro Fertilization Lab, Department of Obstetrics and Gynecology, Virginia Mason Medical Center, University of Washington
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

David Chelmow, MD, Professor of Obstetrics and Gynecology, Tufts University School of Medicine; Program Director, Tufts University Affiliated Hospitals OB/GYN Residency Program; Chair, Tufts University Health Sciences Campus Institutional Review Board
David Chelmow, MD is a member of the following medical societies: American College of Obstetricians and Gynecologists, American Medical Association, Association of Professors of Gynecology and Obstetrics, Massachusetts Medical Society, Phi Beta Kappa, Sigma Xi, Society for Gynecologic Investigation, and Society for Medical Decision Making
Disclosure: Nothing to disclose.

CME Editor

Frederick B Gaupp, MD, Consulting Staff, Department of Family Practice, Assumption Community Hospital
Frederick B Gaupp, MD is a member of the following medical societies: American Academy of Family Physicians
Disclosure: Nothing to disclose.

Chief Editor

David Chelmow, MD, Professor of Obstetrics and Gynecology, Tufts University School of Medicine; Program Director, Tufts University Affiliated Hospitals OB/GYN Residency Program; Chair, Tufts University Health Sciences Campus Institutional Review Board
David Chelmow, MD is a member of the following medical societies: American College of Obstetricians and Gynecologists, American Medical Association, Association of Professors of Gynecology and Obstetrics, Massachusetts Medical Society, Phi Beta Kappa, Sigma Xi, Society for Gynecologic Investigation, and Society for Medical Decision Making
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.